Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra S Diebold

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Plos One|March 13, 2023
Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissueDiana Corogeanu, Kam Zaki, Andrew J Beavil, et al.
International Immunology|June 10, 2009
PolyI:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activationIñigo Tirapu, Benoit Giquel, Lena Alexopoulou, et al.
European Journal of Immunology|November 18, 2006
Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotidesSandra S Diebold, Catherine Massacrier, Shizuo Akira, et al.
Journal of Virology|November 3, 2006
Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9Andreas Pichlmair, Sandra S Diebold, Stephen Gschmeissner, et al.
Cell Reports|July 12, 2018
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated AntigensOliver Schulz, Pavel Hanč, Jan P Böttcher, et al.
Plos One|July 19, 2012
Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificityMartin Kreutz, Benoit Giquel, Qin Hu, et al.
European Journal of Immunology|July 13, 2002
The impact of c-met/scatter factor receptor on dendritic cell migrationSteffen M Kurz, Sandra S Diebold, Thomas Hieronymus, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2019
Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chancesHatem A F M Hassan, Sandra S Diebold, Lesley A Smyth, et al.
European Journal of Immunology|April 3, 2003
Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolinesAlexander D Edwards, Sandra S Diebold, Emma M C Slack, et al.
Plos One|February 19, 2015
Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibodyJantipa Jobsri, Alex Allen, Deepa Rajagopal, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Plos One|March 13, 2023
Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissueDiana Corogeanu, Kam Zaki, Andrew J Beavil, et al.
International Immunology|June 10, 2009
PolyI:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activationIñigo Tirapu, Benoit Giquel, Lena Alexopoulou, et al.
European Journal of Immunology|November 18, 2006
Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotidesSandra S Diebold, Catherine Massacrier, Shizuo Akira, et al.
Journal of Virology|November 3, 2006
Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9Andreas Pichlmair, Sandra S Diebold, Stephen Gschmeissner, et al.
Cell Reports|July 12, 2018
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated AntigensOliver Schulz, Pavel Hanč, Jan P Böttcher, et al.
Plos One|July 19, 2012
Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificityMartin Kreutz, Benoit Giquel, Qin Hu, et al.
European Journal of Immunology|July 13, 2002
The impact of c-met/scatter factor receptor on dendritic cell migrationSteffen M Kurz, Sandra S Diebold, Thomas Hieronymus, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2019
Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chancesHatem A F M Hassan, Sandra S Diebold, Lesley A Smyth, et al.
European Journal of Immunology|April 3, 2003
Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolinesAlexander D Edwards, Sandra S Diebold, Emma M C Slack, et al.
Plos One|February 19, 2015
Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibodyJantipa Jobsri, Alex Allen, Deepa Rajagopal, et al.
Pageof 3